T2 Biosystems, Inc. (TTOO)

USD 0.35

(2.88%)

Long Term Debt Summary of T2 Biosystems, Inc.

  • T2 Biosystems, Inc.'s latest annual long term debt in 2023 was 6.59 Million USD , down -88.6% from previous year.
  • T2 Biosystems, Inc.'s latest quarterly long term debt in 2024 Q2 was 5.74 Million USD , down 0.0% from previous quarter.
  • T2 Biosystems, Inc. reported annual long term debt of 57.86 Million USD in 2022, up 1.25% from previous year.
  • T2 Biosystems, Inc. reported annual long term debt of 57.14 Million USD in 2021, up 2.48% from previous year.
  • T2 Biosystems, Inc. reported quarterly long term debt of 6.18 Million USD for 2024 Q1, down 0.0% from previous quarter.
  • T2 Biosystems, Inc. reported quarterly long term debt of 6.59 Million USD for 2023 Q4, down -6.04% from previous quarter.

Annual Long Term Debt Chart of T2 Biosystems, Inc. (2023 - 2012)

Historical Annual Long Term Debt of T2 Biosystems, Inc. (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 6.59 Million USD -88.6%
2022 57.86 Million USD 1.25%
2021 57.14 Million USD 2.48%
2020 55.76 Million USD 2877.47%
2019 1.87 Million USD 280.69%
2018 492 Thousand USD -71.71%
2017 1.73 Million USD -95.68%
2016 40.29 Million USD 47.62%
2015 27.29 Million USD 32.13%
2014 20.66 Million USD 526.25%
2013 3.29 Million USD -34.78%
2012 5.05 Million USD 0.0%

Peer Long Term Debt Comparison of T2 Biosystems, Inc.

Name Long Term Debt Long Term Debt Difference
Bionano Genomics, Inc. 7.17 Million USD 8.042%
Prenetics Global Limited 867.21 Thousand USD -660.826%
Star Equity Holdings, Inc. 1.14 Million USD -476.245%
CareDx, Inc 28.27 Million USD 76.667%
Exact Sciences Corporation 2.47 Billion USD 99.733%
Exagen Inc. 19.23 Million USD 65.691%
Inotiv, Inc. 399.4 Million USD 98.348%
Guardant Health, Inc. 1.13 Billion USD 99.421%
Biodesix, Inc. 35.22 Million USD 81.269%
BioNexus Gene Lab Corp. 98.76 Thousand USD -6580.64%
Precipio, Inc. 106 Thousand USD -6124.528%
iSpecimen Inc. 29.13 Thousand USD -22550.189%
Natera, Inc. 282.94 Million USD 97.668%
Aspira Women's Health Inc. 1.43 Million USD -361.399%
Standard BioTools Inc. 3.98 Million USD -65.654%
23andMe Holding Co. 67.84 Million USD 90.275%
Castle Biosciences, Inc. 14.19 Million USD 53.529%
Personalis, Inc. 1.23 Million USD -434.684%
Aclaris Therapeutics, Inc. 3.07 Million USD -114.639%
Applied DNA Sciences, Inc. 739.16 Thousand USD -792.632%
OpGen, Inc. 2.02 Million USD -226.373%
Myriad Genetics, Inc. 130.9 Million USD 94.96%
ICON Public Limited Company 3.66 Billion USD 99.82%
NeoGenomics, Inc. 606.06 Million USD 98.911%
Star Equity Holdings, Inc. 1.14 Million USD -476.245%
IDEXX Laboratories, Inc. 622.88 Million USD 98.941%
RadNet, Inc. 812.06 Million USD 99.188%
MDxHealth SA 35.56 Million USD 81.448%
Psychemedics Corporation 945 Thousand USD -598.201%
Illumina, Inc. 1.48 Billion USD 99.557%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 79.17 Million USD 91.666%
DarioHealth Corp. 24.59 Million USD 73.169%
Fulgent Genetics, Inc. 10.11 Million USD 34.744%
Sera Prognostics, Inc. 840 Thousand USD -685.476%
ENDRA Life Sciences Inc. 192.06 Thousand USD -3335.349%
OPKO Health, Inc. 222.03 Million USD 97.028%
Medpace Holdings, Inc. 142.12 Million USD 95.358%
Neogen Corporation 888.39 Million USD 99.257%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -8013.226%
Prenetics Global Limited 867.21 Thousand USD -660.826%
Mainz Biomed B.V. 2.19 Million USD -200.471%
bioAffinity Technologies, Inc. 1.11 Million USD -489.914%
Trinity Biotech plc 54.65 Million USD 87.927%
Neuronetics, Inc. 59.28 Million USD 88.87%
Sotera Health Company 2.22 Billion USD 99.703%
bioAffinity Technologies, Inc. 1.11 Million USD -489.914%